Difference in the expression of Fas/Fas-ligand and the lymphocyte subset reconstitution according to the occurrence of acute GVHD

Bone Marrow Transplantation

Volumn 20, Issue 10, 1997, Pages 883-888

  Lee, S ^a   Chong, S Y ^a   Lee, J W ^a   Kim, S C ^a   Min, Y H ^a   Hahn, J S ^a   Ko, Y W ^a  

^a Yonsei University College of Medicine   (South Korea)

Author keywords

Acute graft versus host disease; CD8+ cells; Fas; Fas ligand

Indexed keywords

CD3 ANTIGEN; CD56 ANTIGEN; CD8 ANTIGEN; FAS ANTIGEN; HLA DR ANTIGEN;

ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; CLINICAL ARTICLE; FEMALE; GRAFT VERSUS HOST REACTION; HUMAN; LYMPHOCYTE SUBPOPULATION; MALE; PRIORITY JOURNAL;

EID: 0030859663     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1700986     Document Type: Article

References (30)

1. Antin JH, Ferrara JLM. Cytokine dysregulation and acute graft-versus-host disease. Blood 1992; 80: 2964-2968.
2. Ferrara JLM, Deeg HJ. Graft-versus-host disease. New Engl J Med 1991; 324: 667-674.
3. Nagata S. Fas and Fas and ligand: a death factor and its receptor. Adv Immunol 1994; 57: 129-144.
4. ++ independent T cell-mediated cytotoxicity. J Exp Med 1993; 177: 195-200.
5. Itoh N, Yonehara S, Ishii A et al. The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 1991; 66: 233-243.
6. Oehm A, Behrmann I, Falk W et al. Purification and molecular cloning of the APO-1 cell surface antigen, a member of the tumor necrosis factor/nerve growth factor receptor superfamily. Sequence identity with the Fas antigen. J Biol Chem 1992; 267: 10709-10715.
7. Suda T, Takahashi T, Golstein P et al. Molecular cloning and expression of the Fas ligand: a novel member of the tumor necrosis factor family. Cell 1993; 75: 1169-1178.
8. Takahashi T, Tanaka M, Brannan CI et al. Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand. Cell 1994; 76; 969-976.
9. Chu JL, Ramos P, Rosendorff A et al. Massive upregulation of the Fas ligand in lpr and gld mice: implications for Fas regulation and the graft-versus-host disease-like wasting syndrome. J Exp Med 1995; 181: 393-398.
10. Theofilopoulos AN, Balderas RS, Gozes Y el al. Association of lpr gene with graft-versus-host disease-like syndrome. J Exp Med 1985; 162: 1-18.
11. Thomas ED, Storb R, Clift RA et al. Bone marrow transplantation. New Engl J Med 1975; 24: 895-902.
12. Sale GE, Lerner KG, Barker EA et al. The skin biopsy in the diagnosis of acute graft-versus-host disease in man. Am J Pathol 1977; 89: 621-635.
13. + T lymphocytes for prevention of graft-versus-host disease after allogeneic bone marrow transplantation. Blood 1990; 73: 418-423.
14. Garin L, Rigal D, Souillet G et al. Allogenic BMT in children: differential lymphocyte subset reconstitution according to the occurrence of acute GVHD. Clin Immunol lmmunopathol 1995; 77: 139-148.
15. Aotsuka N, Asai T, Oh H et al. Lymphocyte subset reconstitution following human allogeneic bone marrow transplantation: differences between engrafted patients and graft failure patients. Bone Marrow Transplant 1991; 8: 345-349.
16. Leino L, Lilius EM, Nikoskelainen J et al. The appearance of 10 differentiation antigens on peripheral blood lymphocytes after allogeneic bone marrow transplantation. Bone Marrow Transplant 1991; 8: 339-344.
17. +) in patients after bone marrow transplantation. Transplantation 1987; 44: 381-386.
18. Gebel HM, Kaiser H, Landay AL. Characterization of circulating suppressor T lymphocytes in bone marrow transplant recipients. Transplantation 1987; 43: 258-263.
19. June CH, Jeffrey AL, Linsley PS, Thompson CB. Role of the CD28 receptor in T-cell activation. Immunol Today 1990; 6: 211-216.
20. Linsley PS, Ledhetter JA. The role of the CD28 receptor during T cell responses to antigen. Annu Rev Immunol 1993; 11: 191-212.
21. - T lymphocytes. Antigenic and functional properties. J Immunol 1993; 150: 1147-1159.
22. + cytotoxic and suppressor T cell clones. J Immunol 1990; 144: 32-40.
23. Lanier LL, Phillips JH. Evidence for three types of human cytotoxic lymphocyte. Immunol Today 1986; 7: 132-134.
24. Li SG, Ottenhoff THM, Van den Elsen P et al. Human T cell clones lack CD28. Eur J Immunol 1990; 20: 1281-1288.
25. Dokhelar MC, Wiels J, Lipinski M et al. Natural killer cell activity in human bone marrow recipients. Early reappearance of peripheral natural killer activity in graft-versus-host disease. Transplantation 1981; 31: 61-65.
26. Ferrara JLM, Guillen FJ, Dijken PJ et al. Evidence that large granular lymphocytes of donor origin mediate acute graft-ver-sus-host disease. Transplantation 1989; 47: 50-54.
27. Keever CA, Klein J, Leong N et al. Effect of GVHD on the recovery of NK cell activity and LAK precursors following BMT. Bone Marrow Transplant 1993; 12: 289-295.
28. Mackinnon S, Hows JM, Goldman JM. Induction of in vitro graft-versus-leukaemia activity following bone marrow transplantation for chronic myeloid leukemia. Blood 1990; 76: 2037-2045.
29. Jiang YZ, Barrett AJ, Goldman JM, Mavroudis DA. Association of natural killer cell immune recovery with a graft-ver-sus-leukemia effect independent of graft-versus-host disease following allogeneic bone marrow transplantation. Ann Hematol 1997; 74: 1-6.
30. Evans R, Faldetta T, Humphreys R et al. Peripheral human T cells sensitized in mixed leukocyte culture synthesize and express la-like antigens. J Exp Med 1978; 148: 1440-1445.